乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Oncology/Hematology >

Leukemia

News, opinions and meeting coverage in oncology/hematology.

A computer rendering of T-cells attacking growing cancer cells.

<乌鸦传媒>When a Revolutionary Cancer Treatment Causes Cancer

The potential benefits of CAR T-cell therapies still far outweigh the risks

A computer rendering of CAR-T immunotherapy.

<乌鸦传媒>CAR-T Investigation: FDA Leaders Detail Decision on Cancer Risk Warning

Post-treatment cases grow to 22 since products' initial approvals

A computer rendering of CAR T cells and a cancer cell.

<乌鸦传媒>FDA Calls for New Boxed Warning on All CAR-T Products

Most serious warning would alert patients, providers on potential risk for secondary malignancies

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer

News, features, and commentary about cancer-related issues

A photo of the packaging and blisterpack of Carvedilol tablets

<乌鸦传媒>Carvedilol No Help in Preventing Heart Failure in Childhood Cancer Survivors

While safe, the results do not support use of the drug in anthracycline-exposed survivors

ASH over a photo of San Diego Convention Center.

<乌鸦传媒>Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia

Investigational drug revumenib now under review at FDA for KMT2A-rearranged disease

ASH over a photo of San Diego Convention Center.

<乌鸦传媒>MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia

No advantage for MRD-negative patients in first remission after induction, regardless of FLT3 ITD

ASH over a photo of San Diego Convention Center.

<乌鸦传媒>Frontline Venetoclax-Ibrutinib for CLL Boosts Survival in Fit Patients

Time-limited approach based on MRD response outperforms FCR, but U.S. applicability unclear

ASH over a photo of San Diego Convention Center.

<乌鸦传媒>Completely Oral Regimen Effective, Feasible in APL

97% of patients alive and relapse-free at 3 years

FDA APPROVED pirtobrutinib (Jaypirca) over a computer rendering of chronic lymphocytic leukemia cells.

<乌鸦传媒>Non-Covalent BTK Inhibitor Approved for CLL

Response rates with pirtobrutinib reached 72% in heavily pretreated patient population

A photo of a young female physician looking at MRI scans of her patient鈥檚 brain.

<乌鸦传媒>Charting the Course: From Young Adult Leukemia Patient to Oncologist

My experience shaped how I care for patients today

A scanning electron microscope image of CAR-T cells attacking a cancer cell.

<乌鸦传媒>FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapy

Applies to all approved therapies, but benefits still outweigh risks, agency says

A photo of a spilled bottle of Eliquis tablets.

<乌鸦传媒>Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL

However, it may benefit children at increased risk of thrombosis

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Wearables as Cancer Monitors; No China Price Break; Cancer Mystery in Appalachia

News, features, and commentary about cancer-related issues

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDS

News, features, and commentary about cancer-related issues

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Lonely Cancer Deaths; Virtual Reality for Pain; 3D Models May Improve Treatment

News, features, and commentary about cancer-related issues

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Chemo Shortage: 'Paycheck to Paycheck'; Cancer Blood Test Shines; Struggling to Live

News, features, and commentary about cancer-related issues

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Cancer Drug Shortages for Kids; Pharma Agrees to Price Talks; Catch-Up on Screening

News, features, and commentary about cancer-related issues

Photos of the box of Zelboraf tablets and the vial of Gazyva over a computer rendering of hairy cell leukemia

<乌鸦传媒>Frontline Combo Yields High Remission Rate in Hairy Cell Leukemia

And almost all complete responders in small trial achieved MRD negativity

SOHO over a photo of George R. Brown Convention Center in Houston, Texas.

<乌鸦传媒>FLT3 Inhibitor Improves AML Survival With or Without Stem-Cell Transplant

Best outcomes with transplantation, but non-transplant patients also benefited from quizartinib

SOHO over a photo of George R. Brown Convention Center in Houston, Texas.

<乌鸦传媒>Early Major Response to Ponatinib in Pretreated CML Portends Better Outcomes

Molecular or cytogenetic response at 3 months correlated with better survival

SOHO over a photo of George R. Brown Convention Center in Houston, Texas.

<乌鸦传媒>Intensive Pretransplant Consolidation in Older AML Fails to Improve Results

Newer therapies and strategies might show more promise for boosting survival

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Microdevices for Glioma; Cervical Adenocarcinoma Test; Language Gaps and Cancer Care

News, features, and commentary about cancer-related issues

SOHO over a photo of George R. Brown Convention Center in Houston, Texas.

<乌鸦传媒>More Intense ALL Therapy Improves Outcomes in Adolescents, Young Adults

Treatment with "pediatric-inspired protocols" improved event-free, relapse-free survival

A photo of bottles of Jaypirca 100 mg and 50 mg.

<乌鸦传媒>Non-Covalent BTK Inhibitor Yields High Response Rate in Pretreated CLL

73% of patients with prior exposure to covalent BTK inhibitors responded

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>WHO Links Sweetener to Cancer; Younger-Age CRC Risk; PCOS and Ovarian Cancer

News, features, and commentary about cancer-related issues

A photo of a bottle of Imbruvica over a computer rendering of chronic lymphocytic leukemia

<乌鸦传媒>No OS Benefit With Ibrutinib in Early-Stage, High-Risk CLL

Study suggests "watch and wait" should remain standard of care

A photo of a little girl wearing a headscarf on a hike with her mother.

<乌鸦传媒>Earlier Detection of Cardiac Dysfunction Possible for Young Adult Cancer Survivors

A case for monitoring global longitudinal strain despite normal LVEF

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Pushback on Price Negotiation; Genetic Testing Lags; More Foreign Help for Shortages

News, features, and commentary about cancer-related issues

A computer rendering of CAR T cells attacking a dividing cancer cell.

<乌鸦传媒>Base-Edited CAR-T Product 'Potent' in Relapsed Childhood T-Cell ALL

One young patient achieved molecular remission within 28 days of infusion

A photo of a box of Breyanzi over a computer rendering of CAR-T cells attacking a cancer cell

<乌鸦传媒>CAR-T for Chronic Lymphocytic Leukemia Hits Goal of Mid-Stage Trial

All patients had progressed on BTK inhibitors and most had failed venetoclax

ASCO over a photo of McCormick place in Chicago, IL.

<乌鸦传媒>Cross-Border Collaboration Improves Survival in Pediatric Leukemia Patients

5-year OS increased to 100% in standard-risk ALL patients at a Tijuana hospital

A photo of the vial and packaging of Mylotarg.

<乌鸦传媒>Adding Mylotarg to Chemo Fails to Boost Survival in NPM1-Mutated AML

But trial detects "meaningful benefit" when it comes to relapse, editorialists say

A photo of a mature man receiving chemotherapy.

<乌鸦传媒>FLT3 Inhibitor Doubles Overall Survival in Acute Myeloid Leukemia

Median OS improved from 15 months to nearly 32 months with quizartinib

A photo of vials of Blincyto over a computer rendering of the destruction of lymphoblast cells

<乌鸦传媒>Blinatumomab Plus Chemo Effective in Aggressive Infant ALL

Low incidence of relapse after treatment "remarkable," researchers say

A photo of a bottle of Iclusig (ponatinib) tablets over a computer rendering of an acute myelogenous leukemia cell

<乌鸦传媒>Targeted Agents Go Head-to-Head for Newly Diagnosed Ph+ ALL

Trial crowns a winner, but how relevant is it amid the changing therapeutic landscape for ALL?

A photo of Nathan Vardi and the cover of his book, For Blood and Money

<乌鸦传媒>The 'Extreme' Story of How Two Game-Changing Cancer Drugs Came to Market

New book by former Forbes senior editor pulls back the curtain on drug development

A computer rendering of T-cells attacking viruses

<乌鸦传媒>Off-the-Shelf T-Cell Therapy Effective Against Viral Infections After Allo-HCT

Produced an antiviral response in 95% of patients with six different types of infection

A photo of a box of Brukinsa capsules over a microscopy of diffuse large B-cell lymphoma cells.

<乌鸦传媒>Zanubrutinib Shows Good Tolerance in BTK-Inhibitor Intolerant Malignancies

Most patients had no recurrence of their original intolerance event

A computer rendering of a macrophage and cancer cells.

<乌鸦传媒>Crystal Ball Cloudy for PI3K Inhibitors' Future in Hematology

After a year of negative news, some caution about throwing out the baby with the bath water

2